Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

23andMe, Inc.

https://www.23andme.com/

Latest From 23andMe, Inc.

Theator Raises $15.5M To Bring AI-Based Surgical Platform To US Academic Medical Centers

Theator plans to expand its AI-powered surgical technology platform beyond general surgery and gain a foothold in the US.

Financing Surgery

Virgin Group Fund Elevates 23AndMe $3.5Bn IPO

23andMe is teaming up with blank check company VG Acquisition Corp to go public, making the move into personalized health care.

23AndMe To Go Public At $3.5Bn With Sir Richard Branson-Backed SPAC

23andMe is teaming up with blank check company VG Acquisition Corp to go public, making the move into personalized health care.

M & A Deals

GSK Venture Capital Arm Goes Independent With $500m Fund

Having been under GSK's umbrella since 1985, SR One is striking out on its own, having closed the largest first-time VC fund this year.

Financing Strategy
See All

Company Information

  • Industry
  • Laboratory Testing Services
  • Services
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Saliva-based Testing
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
UsernamePublicRestriction

Register